Friday, May 12, 2017
Breakfast Meeting
6:30 am - Check-in & Breakfast
6:45 am-7:45 am - Program

Hilton New Orleans Riverside
Room: Fulton, 3rd Level
Two Poydras Street
New Orleans, LA 70130

Organized by the Cardiovascular Research Foundation
Sponsored by CeloNova Biosciences, Inc.

This program is not CME accredited.

There is no cost to register. You must be a SCAI 2017 registrant
to attend these satellite programs.


Treatment options are limited for patients with high-risk of bleeding in need of coronary revascularization. During this satellite symposium, experts share vital knowledge on the COBRA PzF nanocoated coronary stent system, now available for use in your patients. Learn about the unique cobalt chromium stent platform and the cutting edge Polyzene –F (PzF) nanometer-thin polymer coating used in this stent system. Hear the clinical evidence of effectiveness and the pivotal study results that led to US FDA approval of this system. Gain insight into how you might incorporate this novel coronary device into your practice through problem-based and case-based presentations.

Learning Objectives

At the end of this program, the attendees will be able to:

  • Describe the current challenges of treating patients with high-risk of bleeding
  • Describe the COBRA PzF nanocoated coronary stent system
  • Discuss why the COBRA PzF stent system offers advantages over other coronary stent products
  • Explain why use of the COBRA PzF stent system may offer economic advantages for patients at high-risk of bleeding
  • Describe ongoing clinical research on the COBRA PzF stent system, and how the results of future work may influence coronary therapies

This educational activity is designed for interventional cardiologists, clinical cardiologists, and other healthcare professionals involved in the management of patients with cardiovascular disease.

Evaluation by questionnaire will address content, presentations, and future educational needs.

It is the policy of the Cardiovascular Research Foundation to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. Commercial support from industry does not influence educational content, faculty selection, and/or faculty presentations, and therefore, does not compromise the scientific integrity of the educational activity.

Discussion of off-label product usage is made at the sole discretion of the faculty. Off-label product discussion and usage is not endorsed by the Cardiovascular Research Foundation, nor the course directors of this activity.

Faculty participating in medical education activities sponsored by the Cardiovascular Research Foundation are required to disclose to the activity audience any real or apparent conflicts of interest related to the content of their presentations. Faculty in noncompliance with this policy are not permitted to participate in this activity.

This program is organized by the Cardiovascular Research Foundation and sponsored by CeloNova BioSciences, Inc. The Cardiovascular Research Foundation ensures that its programs are educational and meet the needs of the target audience.

This activity is not CME accredited, and therefore the supporter is required under the Sunshine Act (as part of the Affordable Care Act) to track and report all payments and transfers of value to US licensed physicians, including meals and expenses that are provided to you. In order to help supporters comply with the Sunshine Act, the names and contact information of all US and Canadian licensed physicians participating in this function will be provided to the supporter of this program. The information provided will be used for reporting purposes only.

Should you partake in this program, you will be reported as part of the Sunshine Act submission and will appear on the CMS Open Payments website on the next reporting cycle.


Vermont laws prohibit this program from providing any complimentary food, meals, or refreshments to healthcare professionals licensed by and regularly practicing in Vermont. Accordingly, healthcare professionals licensed by and practicing in Vermont are requested not to register for this program.



Kirk N. Garratt, MD, MSc, FSCAI Christiana Hospital Delaware
Newark, DE

Roxana Mehran, MD, FSCAI Mount Sinai Medical Center
New York, NY


David J. Cohen, MD, FSCAI Saint Luke's Mid America Heart Institute
Kansas City, MO

Rajiv Jauhar, MD, FSCAI Northwell Health
Manhasset, NY

Perwaiz M. Meraj, MD, FSCAI Northwell Health
Manhasset, NY



{{}} and {{lecturer}}, and {{case_presenter}},



{{}} and {{lecturer}}, and {{case_presenter}},



{{}} and {{lecturer}}, and {{case_presenter}},


There is no cost to register. You must be a SCAI 2017 registrant to attend this satellite program.

Should you have any questions, please contact
Catherine Brosnan at

Register Now